T: 01243 786993 | Contact

May 2023

May 31, 2023

The New Alzheimer’s drug slows cognitive decline by 35%, trial results show

« Back to News

I consent to the use of following cookies:

Necessary

Marketing

Analytics

Preferences

Unclassified

Cookie Declaration About Cookies

Necessary (5) Marketing (6) Analytics (1) Preferences (0) Unclassified (0)

Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

Name	Domain	Purpose	Expiry	Type
DYNSRV	www.donnaockenden.com	Saves which load balancer you are using to ensure a consistent browsing experience	52 years	---
lang	cdn.syndication.twimg.com	User language preference cookie.	52 years	HTTP
sl_message	www.donnaockenden.com	Used by our hosting provider to load balancing	141 days	HTTP
wpl_user_preference	donnaockenden.com	Stores your cookie preferences	1 week	HTTP
wpl_viewed_cookie	donnaockenden.com	Stores if you have seen the cookie notice or not	1 week	HTTP

Name	Domain	Purpose	Expiry	Type
YSC	YouTube.com	This cookie is set by YouTube and is used to track the views of embedded videos	Session	HTTP
VISITOR_INFO1_LIVE	YouTube.com	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website	5 months 27 days	HTTP
IDE	doubleclick.net	Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.	1 year 24 days	HTTP
test_cookie	doubleclick.net	This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user’s browser supports cookies.	15 minutes	HTTP
yt-remote-device-id	YouTube.com	This cookie is set via embedded YouTube videos	Never	HTTP
yt-remote-connected-devices	youtube.com	This cookie is set via embedded YouTube videos	Never	HTTP